Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Konig; Wolfgang
Address:
Stallwang, DE
No. of patents:
7
Patents:




Patent Number Title Of Patent Date Issued
6191282 Substituted 5-membered ring heterocycles comprising a bicyclic or tricyclic group their preparat February 20, 2001
5-Membered ring heterocycle of the formula I, ##STR1##in which D includes a COOR.sup.15, CON(CH.sub.3)R.sup.15 or CONHR.sup.15 radical and R.sup.15 includes a 6-24 member bicyclic or tricyclic radical, compositions, preparation and use as inhibitors of thrombocyte aggregation, metast
5981492 Substituted 5-membered ring heterocycles, their preparation and their use November 9, 1999
The present invention pertains to 5-ring heterocycles of general formula (I), wherein W, Y, Z, B, D, E and R as well as b, c, d, e, f, g, and h are as indicated in the description; to methods for preparing them, and to their use as inhibitors of platelet aggregation, metastasizing of
5703050 Urea derivatives, their preparation and use December 30, 1997
Urea derivates are disclosed having the formula (I). ##STR1## in which A, B, W, Z, R, R.sup.1, R.sup.2, R.sup.3 and r have the meaning given in the description, as well as a process for preparing the same and their use as inhibitors of thrombocyte aggregation, carcinom cell metas
5681838 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggreg October 28, 1997
The present invention relates to novel substituted amino compounds of the formula I:as defined in the present application, and to a process for preparing such compounds. The invention also includes pharmaceutical compositions containing the present compounds, and the preparation of such
5658935 Heterocycles, their preparation and their use August 19, 1997
The invention concerns heterocyclic compounds of the general formula (I) in which A, B, R, R.sup.2, R.sup.3, W, Y, Z.sup.1, Z.sup.2 and r are as defined in the description, methods of preparing them and their use as inhibitors of thrombocyte aggregation, the metastization of carcinoma
5554594 Imidazolidine derivatives September 10, 1996
The present invention relates to compounds of the general formula I ##STR1## in which R, R.sup.1 to R.sup.4, r, Y, Z and W are defined as indicated in the description, a process for their preparation and their use as inhibitors of platelet aggregation, metastasis of carcinoma cells a
5424293 Phenylimidazolidine derivatives and their use June 13, 1995
Phenylimidazolidine derivatives of the general formula I ##STR1## in which, for example, Y denotes --CH.sub.2 --CH.sub.2 --CO--r denotes 0 to 3Z denotes oxygenW denotes hydroxylR.sup.1 denotes --NH--C(.dbd.NH)--NH.sub.2R, R.sup.2, R.sup.3 denote hydrogenR.sup.4 denotes --CO--NHR.sup.5,where


 
 
  Recently Added Patents
Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors
Hardware simulation using a test scenario manager
Dispensing apparatus for plastic bags
Data backup method
System and method for designing a network
Multiple testing bars for testing liquid crystal display and method thereof
Nail polish remover
  Randomly Featured Patents
Wireless phone-line interface
Low loss optical fiber and method for making same
Hinge assembly for a device having a display
Staggered thin film transistor with transparent electrodes and an improved ohmic contact structure
Hydraulic safety joint
Division directing device for blood testing
System and method for simplifying different types of searches in electronic program guide
Integrated circuit having a reduced spacing between a bus and adjacent circuitry
Laser crystallization method suppressing propagation of cracks forming a display device
Pushbutton switch or pushbutton-actuated slide switch